News for Cano Health, Inc. (CANO)

After a series of public market collapses, investors and bankers have strict standards for healthcare startups hoping to IPO this year.

For Q3 2024, the fund's Retail Class shares gained 5.28%, matching the benchmark, the ICE BofA US High Yield Constrained Index. Click here to read the full commentary.

The healthcare sector has seen a slowdown in bankruptcies, but financial challenges persist, especially among large firms, according to a recent report. Read more here.

By Ben Glickman Cano Health said it reached a deal with the committee representing unsecured creditors and received court approval for its disclosure statement. The primary care provider,...

Cano Health expects to emerge from Chapter 11 bankruptcy in Q3, after approval of its agreement with Unsecured Creditors Committee and Ad Hoc Lender Group...

In March, fallen angels outperformed the broad high yield market. The majority of the outperformance can be attributed to tighter credit spreads. Click to read.

Cano Health executives sell over $114k in MSP Recovery shares

Year-to-date, fallen angels are behind by 0.14%, posting returns of 0.17% versus 0.32% for the broad high yield market.

Operator: Welcome to Monroe Capital Corporation's Fourth Quarter and Full Year 2023 Earnings Conference Call.

Elevated borrowing costs take their toll, with 29 companies having defaulted this year

The real estate mogul wants to merge hotels owned by his investment firm Starwood Capital with a blank check company he controls.

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Cano Health shares plummet to record low amid liquidity fears

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

P3 Healthcare’s stock price plummeted by ~80% since its Nasdaq listing. Since June’s hold recommendation, stock price is down >50%. Find out why PIII stock is a Sell.

Cano Health CEO Dr. Marlow Hernandez has stepped down amid pressure from key stakeholders. Check out what this means for CANO shareholders.

P3 Health Partners went public in December 2021 via a SPAC merger. Read more about PIII stock here.